Save the Date for the “22nd International Symposium on Signal Transduction at the Blood-Brain Barriers”

Press Release / 28.2.2019

Protecting the brain from pathogens, toxins or other harmful substances is one major function of the blood-brain barrier.  This is ensured by tight junctions between endothelial cells (green); cell nuclei are shown in blue.
© University Hospital Würzburg

Protecting the brain from pathogens, toxins or other harmful substances is one major function of the blood-brain barrier. This is ensured by tight junctions between endothelial cells (green); cell nuclei are shown in blue.

The Fraunhofer Institute for Silicate Research ISC and the University Hospital Würzburg host the “22nd International Symposium on Signal Transduction at the Blood-Brain Barriers”, which will be held from September 11 – 13, 2019 in Würzburg, Germany.

The Symposium covers the latest developments in blood-brain barriers research including novel concepts in drug delivery across the brain barriers, in vitro modeling, new approaches in engineering brain barriers, molecular mechanisms regulating the barrier integrity, or the role of blood-brain barriers in infection.

Scientific sessions including two poster sessions, extensive breaks and two evening events will offer many opportunities for discussions and academic exchange. Promotion of young scientists, clinicians, and academics is a particular aim of this conference. A significant number of speakers will be selected from abstracts submitted by young scientists. The program will be completed by invited keynote lectures to present the international perspective within this fast growing research field.

The deadline for submission of poster abstracts to be considered for oral and poster presentation is June 15, 2019.
The deadline for the early bird registration is Mai 1, 2019.

The website www.bbb-conference.fraunhofer.de offers more information about the program, the registration, the committees, and the guidelines for oral and poster presentations.



The Organizing Committee:

PD Dr. Marco Metzger, Fraunhofer Translational Center Regenerative Therapies TLC-RT (Fraunhofer ISC Würzburg)
PD Dr. Malgorzata Burek, Department of Anaesthesia and Critical Care (University Hospital Würzburg)
Dr. Antje-Appelt Menzel, Tissue Engineering and Regenerative Medicine TERM (University Hospital Würzburg)
PD Dr. Winfried Neuhaus, Center Health and Bioressources (AIT Austrian Institute of Technology Wien)